Media Bulletin

Schwartz wins PR accounts for three cancer treatment firms

By Staff

15th September 2010

Category: PR

Following on from its recent signing of melanoma vaccine client, Scancell, Schwartz Communications UK has signed three oncology accounts.

– UK-based Microsulis, which uses microwave technology to destroy previously inoperable tumours

– global health science company MDS Nordion which provides products and services used for the prevention, diagnosis and treatment of disease, specifically liver cancer treatments

– South Korea-based KAEL-GemVax, which is developing new cancer vaccines to enhance survival while maintaining a high quality of life for patients

[lnk|http://www.schwartzcomm.com|_blank|Schwartz Communications UK Limited]

Links for media database subscribers

Not a media database subscriber?

No links attached.

Related news

24th February 2017 PR

Mash PR retained by NRAS

24th February 2017 PR

House PR joins forces with W for London Art Week

23rd February 2017 PR

WildKat PR chosen by Sound and Music

New! Check out our Media Jobs board for PR and Journalism vacancies Learn more